🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

David M. Kendall

Zealand Pharma (Denmark)

ORCID: 0000-0003-1910-2587
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Dasiglucagon for the Treatment of Congenital Hyperinsulinism: A Randomized Phase 3 Trial in Infants and Children”.

Dasiglucagon for the Treatment of Congenital Hyperinsulinism: A Randomized Phase 3 Trial in Infants and Children

The Journal of Clinical Endocrinology & Metabolism(2023)10.1210/clinem/dgad648
N/A
0DataRank · unranked
11 citations

Diva D. De León, Susann Empting, David Zangen, David M. Kendall, Sune Birch +4 more